Similarly, BRAF (V600E), the most common mutation in melanoma, correlates with DRP1 phosphorylation in melanoma tumor tissues, whereas MAPK inhibition reverses DRP1-mediated mitochondrial fission, and sensitizes cells to mitochondrial-targeting drugs [34]. This evidence concerns the gene BRAF and neoplasm.